Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eleven analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $133.2222.
ADUS has been the subject of a number of analyst reports. Wall Street Zen cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. Royal Bank Of Canada reissued an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Wednesday, February 25th. Stephens cut their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Finally, KeyCorp reiterated an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th.
Read Our Latest Report on ADUS
Insider Buying and Selling at Addus HomeCare
Institutional Trading of Addus HomeCare
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Global Retirement Partners LLC lifted its holdings in shares of Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after buying an additional 186 shares during the last quarter. Larson Financial Group LLC grew its stake in shares of Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after acquiring an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC acquired a new stake in shares of Addus HomeCare in the fourth quarter worth $29,000. Private Trust Co. NA increased its position in Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after acquiring an additional 112 shares during the period. Finally, Arax Advisory Partners raised its stake in Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.
Addus HomeCare Price Performance
Addus HomeCare stock opened at $95.19 on Friday. The company has a market capitalization of $1.77 billion, a P/E ratio of 18.27, a P/E/G ratio of 1.32 and a beta of 0.92. The firm’s fifty day simple moving average is $105.75 and its 200-day simple moving average is $111.07. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.11. Addus HomeCare has a 1-year low of $94.39 and a 1-year high of $124.43.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Articles
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
